IPA लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (8 May 2024 @ 01:30):

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally...

Stats
आज की मात्रा	62 387.00
औसत मात्रा	602 121
बाजार मूल्य	33.68M
EPS	$0 ( 2024-03-21 )
अगली कमाई की तारीख	( $-0.100 ) 2024-07-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.05
ATR14	$0.00800 (0.63%)

Insider Trading

Date	Person	Action	Amount	type
2008-12-12	Aisling Capital Ii Lp	Buy	861 826	Convertible 12% Note Due 2009
2008-12-12	Aisling Capital Ii Lp	Buy	10 412	Series D-1 Convertible Preferred Stock
2008-12-12	Aisling Capital Ii Lp	Buy	1	Warrant (right to buy)
2008-12-12	Aisling Capital Ii Lp	Buy	1	Warrant (right to buy)
2008-12-12	Aisling Capital Ii Lp	Sell	10 000	Series C-1 Convertible Preferred Stock

INSIDER POWER
0.00
Last 20 transactions
Buy: 4 917 425 \| Sell: 9 058 105

ImmunoPrecise Antibodies सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
CBNK	0.964
ALRS	0.959
BWB	0.957
WTBA	0.956
UTHR	0.956
KNSA	0.955
HALO	0.952
SFST	0.951
AROW	0.951
WASH	0.95

10 सबसे अधिक नकारात्मक सहसंबंध
DUOL	-0.959
SVFAU	-0.957
LGACU	-0.957
APXI	-0.956
SVFA	-0.953
SCOB	-0.952
DSEY	-0.952
ALTR	-0.951
LGAC	-0.951
NVDA	-0.951

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

ImmunoPrecise Antibodies वित्तीय

Annual	2022
राजस्व:	$20.67M
सकल लाभ:	$11.56M (55.95 %)
EPS:	$-1.070

FY	2022
राजस्व:	$20.67M
सकल लाभ:	$11.56M (55.95 %)
EPS:	$-1.070

FY	2022
राजस्व:	$19.36M
सकल लाभ:	$10.98M (56.72 %)
EPS:	$-0.850

FY	2021
राजस्व:	$17.91M
सकल लाभ:	$11.54M (64.41 %)
EPS:	$-0.450

Financial Reports:

No articles found.

ImmunoPrecise Antibodies

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.